わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/04/05 | 日証協 | 137,409株 | +4.89% | 158,700株 | -41.55% | 219,535株 | +22.5% | 24,700株 | -52.61% |
2019/03/29 | 日証協 | 131,009株 | +12.45% | 271,500株 | +1145.41% | 179,218株 | -12.93% | 52,117株 | +111.86% |
2019/03/22 | 日証協 | 116,509株 | +13.66% | 21,800株 | -87.1% | 205,833株 | +6.35% | 24,600株 | +32.97% |
2019/03/15 | 日証協 | 102,509株 | +7.1% | 169,000株 | +132.46% | 193,534株 | +4.54% | 18,500株 | -56.26% |
2019/03/08 | 日証協 | 95,709株 | +6.57% | 72,700株 | +45.69% | 185,134株 | +4.69% | 42,300株 | +164.38% |
2019/03/01 | 日証協 | 89,809株 | +0.66% | 49,900株 | -28.41% | 176,834株 | -14.59% | 16,000株 | +138.81% |
2019/02/22 | 日証協 | 89,221株 | -7.56% | 69,700株 | +52.85% | 207,034株 | -2.08% | 6,700株 | -52.48% |
2019/02/15 | 日証協 | 96,521株 | -13.76% | 45,600株 | -3% | 211,434株 | -8.48% | 14,100株 | -50% |
2019/02/08 | 日証協 | 111,921株 | +32.11% | 47,012株 | -61.66% | 231,034株 | +34.22% | 28,200株 | -66.71% |
2019/02/01 | 日証協 | 84,721株 | +17% | 122,612株 | +294.14% | 172,134株 | +9.69% | 84,700株 | +197.19% |
2019/01/25 | 日証協 | 72,412株 | +13.83% | 31,109株 | +36.44% | 156,934株 | +11.2% | 28,500株 | +54.05% |
2019/01/18 | 日証協 | 63,612株 | -8.22% | 22,800株 | -18.31% | 141,134株 | -13.49% | 18,500株 | -11.9% |
2019/01/11 | 日証協 | 69,312株 | -15.16% | 27,912株 | +206.73% | 163,134株 | +6.95% | 21,000株 | +356.52% |
2019/01/04 | 日証協 | 81,700株 | -0.12% | 9,100株 | -80.43% | 152,534株 | +0.59% | 4,600株 | -33.22% |
2018/12/28 | 日証協 | 81,800株 | +14.41% | 46,500株 | +511.84% | 151,634株 | 0% | 6,888株 | -36.81% |
2018/12/21 | 日証協 | 71,500株 | -13.86% | 7,600株 | -79.23% | 151,634株 | +16.52% | 10,900株 | -71.76% |
2018/12/14 | 日証協 | 83,000株 | +4.8% | 36,600株 | -6.63% | 130,134株 | +0.7% | 38,600株 | +135.19% |
2018/12/07 | 日証協 | 79,200株 | +0.36% | 39,200株 | +2.02% | 129,234株 | -1.82% | 16,412株 | +33.43% |
2018/11/30 | 日証協 | 78,912株 | +8.4% | 38,424株 | +154.46% | 131,634株 | -21.57% | 12,300株 | +83.58% |
※株式分割は考慮していませんのでご注意ください。
Page Top